NCT04217512

Pantoprazole in Cisplatin Nephrotoxicity

Possible Protective Effect of Pantoprazole in Cisplatin Induced Nephrotoxicity in Patients With Head and Neck Cancer

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Sherief Abd-Elsalam · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Pantoprazole in Cisplatin Nephrotoxicity

Detailed description

Pantoprazole in Cisplatin NephrotoxicityPantoprazole in Cisplatin Nephrotoxicity. Is it protective?

Conditions

• Oncology

Interventions

Type	Name	Description
DRUG	Pantoprazole low dose	Pantoprazole 0.6 mg/kg
DRUG	Pantoprazole high dose	Pantoprazole 1.6 mg\\kg
OTHER	Standard hydration	Standard hydration alone
DRUG	Cisplatin	Cisplatin

Timeline

• Start date: 2019-05-01
• Primary completion: 2030-12-01
• Completion: 2030-12-30
• First posted: 2020-01-03
• Last updated: 2020-01-03

Locations

1 site across 1 country: Egypt